Beverages

Coffee's evidence has solidified in its favour; alcohol's J-curve has collapsed; tea sits between them with a smaller but consistent positive signal. And the unsexy one — water — turns out to matter more than people thought, both for biological aging and for what's actually in the bottle.

Four beverages dominate the longevity conversation: water, coffee, tea, and alcohol. The evidence on each has shifted notably in the last decade. Water is no longer "drink eight glasses" folklore — chronic mild dehydration tracks with measurably faster biological aging, and per- and polyfluoroalkyl substance (PFAS) and microplastic contamination of municipal and bottled supplies has made filtration choices a real longevity decision. Coffee has accumulated a remarkably consistent positive signal across major outcomes — mortality, type 2 diabetes, liver disease, several cancers, and now atrial fibrillation. Tea shows smaller, less rigorously studied benefits in the same general direction. Alcohol's historical "J-curve" cardio-protection has largely collapsed under Mendelian randomisation scrutiny, and the WHO's 2023 position that "no level of alcohol consumption is safe" is increasingly the consensus.

The other useful framing: what you don't drink matters as much as what you do. Sugar-sweetened beverages, alcohol after the first drop, and pure-water alternatives that turn out to deliver microplastics with each bottle are all on the negative side of the ledger.

What the evidence actually supports

Strong:

  • Coffee at 2–4 cups per day is associated with the lowest all-cause mortality across multiple large cohorts. A meta-analysis pooling 40 cohort studies across roughly 3.85 million adults found the nadir at 3.5 cups per day, with about 15% lower all-cause mortality at the optimum.[1] A UK Biobank cohort of 171,616 adults found 1.5–3.5 cups per day associated with 29–31% lower all-cause mortality.[2] Both caffeinated and decaffeinated forms show benefit. See Coffee.
  • Alcohol's J-curve has collapsed. Genetic-instrument analyses find monotonic harm with no protective threshold — the China Kadoorie Biobank cohort of 512,000 adults found any genetically predicted increase in alcohol raised blood pressure and stroke incidence linearly.[3] The WHO's January 2023 position is that no level of alcohol consumption is safe.[4] See Alcohol.
  • Alcohol is a Group 1 carcinogen. A landmark dose-response meta-analysis covering 572 studies and 486,538 cancer cases found clean monotonic dose-response curves — even light drinking (≤1 drink/day) carries elevated breast, oral, and oesophageal cancer risk.[5] The US Surgeon General's January 2025 advisory identified alcohol as the third leading preventable cause of cancer in the US, after tobacco and obesity.[6]
  • Chronic mild dehydration accelerates biological aging. A 2023 analysis of the Atherosclerosis Risk in Communities (ARIC) cohort following 15,752 US adults for 25 years found that serum sodium chronically above 142 mmol/L — driven by low water intake — was associated with up to 50% higher odds of being biologically older than chronological age and roughly 39% higher chronic-disease risk.[7] The entire 137–146 mmol/L range is labelled "normal" by lab reference — the risk gradient sits inside that window. See Water.

Moderate:

  • Coffee and type 2 diabetes: each cup per day reduces incident type 2 diabetes risk by about 6%.[8]
  • Coffee and atrial fibrillation: the 2025 DECAF randomised trial in patients post-cardioversion for atrial fibrillation found one or more cups per day of caffeinated coffee reduced atrial fibrillation recurrence by 39%, directly challenging the long-standing avoidance instruction.[9]
  • Coffee and liver cancer: each additional 2 cups per day reduces hepatocellular carcinoma risk by about 35%.[10]
  • Tea and dementia: a 2026 JAMA analysis pooling the Nurses' Health Study and Health Professionals Follow-Up Study — 131,821 adults followed for 43 years — found 1–2 cups of tea per day associated with 18% lower dementia risk, comparable to 2–3 cups of caffeinated coffee.[11] See Tea.
  • Tea and bone density: a 2025 meta-analysis covering roughly 560,000 adults found tea drinkers had lower osteoporosis risk; polyphenol effects on osteoclasts probably outweigh the small caffeine-induced calcium loss.[12]
  • Hydration for clinical endpoints: a 2024 JAMA Network Open systematic review of 18 RCTs found replicated benefit for weight management, kidney stones, migraine prophylaxis, recurrent urinary-tract infections, and orthostatic vertigo.[13]

Weak / preliminary:

  • Hydrogen water has plausible biology and small RCTs; not yet conclusive.
  • Successful Aging Index–green tea associations (ATTICA/MEDIS 2019) are real but cross-sectional and confounded — green tea drinkers were also more physically active and less hypertensive at baseline.[14]

Caution:

  • Sugary coffee drinks cancel most of coffee's benefit and add substantial calories — the signal is for black or near-black coffee, not for what's served at the chain.
  • Concentrated green-tea-extract supplements carry rare but real hepatotoxicity reports; brewed tea does not.
  • Microplastics and PFAS in bottled water. A global survey of 11 major bottled-water brands found 93% contained microplastics — averaging 325 particles per litre, mostly more than tap water.[15] PFAS exposure links to immunosuppression, thyroid disruption, dyslipidaemia, and reproductive harm.[16]
  • Tea and non-heme iron absorption: tea inhibits iron uptake more than coffee does, which matters for menstruating women, plant-based eaters, and anyone on iron therapy — separate tea from iron-rich meals by 60–90 minutes.[17]

Water: the underrated lever

For decades, hydration science was binary: you were either fine or clinically dehydrated, and anything in between was thought irrelevant. The 2023 ARIC analysis broke that view by showing that serum sodium at the high end of the "normal" range — driven mostly by chronic low water intake — predicts accelerated biological aging, chronic disease, and earlier death.[18] The middle of the reference range is where lowest risk sits; the top quartile (still inside "normal") carries about 50% higher odds of being biologically older than chronological age and around 21% higher premature mortality above 144 mmol/L. A parallel Israeli cohort of 407,187 adults healthy at baseline confirmed the same signal — serum sodium ≥140 mmol/L independently predicted incident hypertension and heart failure.[19]

How you drink also matters more than expected. Bolus drinking — chugging a large volume in a short window — captures only about 55% of the fluid into long-term hydration; metered sipping captures around 75%, with a 64% rise in Beverage Hydration Index and 26–32% less urine output for the same total volume.[20] A sudden flood drops plasma osmolality fast, the hypothalamus suppresses antidiuretic hormone, and the kidneys clear most of the water before it reaches the intracellular compartments. Metered intake keeps the regulation steady.

The modern wrinkle is what's in the water. Microplastics and nanoplastics are now ubiquitous in tap and bottled supplies — and the particles do not pass inertly through. Nanoplastics cross the gut lining and have been recovered from human blood, lung, and placenta, where they trigger localised chronic inflammation and act as carriers for endocrine-disrupting plasticisers.[21] PFAS — virtually indestructible carbon-fluorine compounds — accumulate in groundwater and human serum with documented links to immunosuppression and reproductive harm.[22] Reverse-osmosis filtration with remineralisation is the protocol of choice for most modern municipal supplies; mineral-stripping RO without remineralisation actively works against the magnesium signal in drinking water.

Water covers the serum-sodium dose-response in full, the bolus-vs-metered physiology, the PFAS and microplastic literature, filter technology comparison, the honest read on "functional waters" (hydrogen, alkaline, structured, marine plasma), and the magnesium-in-drinking-water mortality cohort.

Coffee: the most consistently positive beverage on the longevity ledger

Coffee accumulates a remarkably clean signal across major endpoints. An umbrella review of 201 meta-analyses put the mortality nadir at 3 cups per day;[23] the 40-cohort, 3.85-million-adult meta-analysis put it at 3.5;[24] a UK Biobank cohort of 449,000 found the greatest mortality reduction at 2–3 cups across ground (27% lower), instant (11%), and decaffeinated (14%) forms.[25] The fact that decaffeinated coffee shows benefit suggests non-caffeine constituents — chlorogenic acids and other polyphenols — are doing meaningful work, not just the caffeine.

Beyond mortality, the disease-specific signals are coherent. A pooled cardiovascular cohort covering 1.28 million adults found a J-shape with lowest risk at 3–5 cups per day.[26] Each cup per day reduces incident type 2 diabetes by about 6%,[27] and each additional 2 cups per day cuts hepatocellular carcinoma risk by about 35%.[28] The most surprising recent finding: the 2025 DECAF randomised trial reversed the long-standing instruction to avoid coffee in atrial fibrillation — one or more cups per day of caffeinated coffee reduced atrial-fibrillation recurrence by 39% in patients post-cardioversion.[29]

The European Food Safety Authority and US FDA converge on up to 400 mg of caffeine per day as safe for healthy adults, with a 200 mg ceiling in pregnancy. The signal is for unsweetened coffee — adding sugar in any quantity neutralises most of the benefit, and concentrated mycotoxin and acrylamide concerns are addressed by reasonable bean and roast choices.

Coffee covers the dose-response across endpoints, the AF-and-coffee story before and after DECAF, the iron-and-calcium interaction (separate by 60–90 minutes), the filtered-vs-unfiltered question (cafestol and kahweol raise LDL slightly), Mendelian-randomisation caveats, and why decaffeinated and caffeinated track together for most outcomes.

Tea: a smaller, parallel signal

Tea sits in the same general direction as coffee but with smaller effect sizes and a thinner evidence base. The most striking recent result is the 2026 JAMA analysis pooling the Nurses' Health Study and the Health Professionals Follow-Up Study — 131,821 adults followed for 43 years — which found 1–2 cups of tea per day associated with 18% lower dementia risk, comparable to 2–3 cups of caffeinated coffee, holding across Alzheimer's and vascular subtypes.[30] Black tea benefits plateau around 2 cups per day; green tea shows closer to a linear response up to 3–4 cups.

The mechanisms are partly polyphenol-driven. Green-tea polyphenols are extensively metabolised by gut microbes and reciprocally shape microbial communities — Akkermansia muciniphila, a mucin-layer commensal with strong metabolic-health links, is one of the populations involved.[31] A 2025 meta-analysis covering roughly 560,000 adults found tea drinkers had reduced osteoporosis risk, with a 2025 Flinders cohort confirming higher hip bone mineral density in daily tea drinkers aged 65+.[32]

The one practical caution: tea inhibits non-heme iron absorption substantially more than coffee — separating tea from iron-rich meals or supplements by 60–90 minutes neutralises the interaction.[33] The interaction is local to the gut lumen, not a systemic depletion, but matters for menstruating women, plant-based eaters, and anyone on iron therapy. Concentrated green-tea-extract supplements have rare hepatotoxicity reports; brewed tea does not.

Tea covers green-vs-black, the L-theanine question, the iron interaction in detail, the bone-density evidence, polyphenol bioavailability, and an honest read on the "Successful Aging Index" signal from cross-sectional Mediterranean cohorts.

Alcohol: the J-curve collapse

For 30 years, observational cohort data showed a U- or J-shaped relationship between alcohol intake and cardiovascular mortality — light-to-moderate drinkers appeared healthier than abstainers. That curve has collapsed under three methodological pressures: better handling of "sick quitters" (former drinkers reclassified as abstainers), the rise of Mendelian-randomisation studies using genetic variants as instruments, and an expanding cancer signal that the cardiovascular story had been masking.

The genetic-instrument data is the most consequential. The China Kadoorie Biobank cohort of 512,000 adults found any genetically predicted increase in alcohol raised blood pressure and stroke incidence linearly, with no protective threshold.[34] A 94-SNP analysis found odds ratio 1.27 for stroke and 3.05 for peripheral artery disease per one-standard-deviation increase in drinks per week.[35] A UK Biobank MR found each additional daily drink causally associated with a 2.65 mmHg rise in systolic blood pressure, odds ratio 2.25 for haemorrhagic stroke, and 1.26 for atrial fibrillation.[36] A 2024 Million Veteran Program analysis replicated the U-shape observationally but found no causal benefit at moderate intake in MR.[37]

The cancer side is unambiguous. The Bagnardi dose-response meta-analysis covering 572 studies and 486,538 cases found clean monotonic curves — breast, oral, oesophageal, colorectal, and liver cancer risk all rise from the first drop, with no protective dose.[38] Acetaldehyde, the first metabolic product of ethanol, is the proximate carcinogen; the ALDH2*2 East Asian variant — which slows acetaldehyde clearance and produces facial flushing — confirms causality via natural-experiment data showing flushers carry sharply higher upper-aerodigestive cancer risk for the same intake. The WHO's January 2023 position is unambiguous: "no level of alcohol consumption is safe for our health".[39] The US Surgeon General's January 2025 advisory identified alcohol as the third leading preventable cause of cancer in the US.[40] Even moderate drinking is associated with reduced grey-matter and hippocampal volume in cohort imaging.[41]

Alcohol covers the J-curve collapse in detail, the MR data, the ALDH2 natural experiment, the cancer dose-response by site, the brain-imaging signal at "moderate" intake, the NASEM 2025 cardiovascular nuance (some benefit may survive in studies excluding former drinkers), and Canada's 2023 low-risk guidance of less than two drinks per week.

Practical beverage guidance

  1. Coffee, 2–4 cups per day, filtered or unfiltered (filtered reduces a small LDL bump from cafestol/kahweol). Watch evening timing — caffeine half-life is 3–6 hours and varies with genotype.
  2. No added sugar in coffee. Black, with milk, or with cinnamon is fine; sugary coffee drinks cancel most of the benefit.
  3. For alcohol, the minimum-risk dose is at or near zero. Cancer risk begins from the first drop; don't start drinking for "heart benefits" — those don't survive rigorous methods. If you currently drink, less is better. Canada's 2023 guidance is under two drinks per week as the lower-risk threshold.
  4. Drink water steadily, not in boluses. Roughly 2–3 L per day of total fluids for most healthy adults; pale-yellow urine and rare thirst are the real biomarkers. Filter for PFAS and microplastics; reverse osmosis with remineralisation handles most modern municipal supplies.
  5. Tea (green or black), 1–3 cups per day, separated from iron-rich meals or supplements by 60–90 minutes if iron status is a concern.
  6. Sugar-sweetened beverages are off the list. They aren't on the same axis — they're on the negative side of the ledger, alongside alcohol.

What's overrated

  • "Wine is healthy because of resveratrol." Wine contains 0.3–1 mg of resveratrol per glass; therapeutic doses in research are 100–500 mg. The observational cardiovascular signal is overwhelmingly explained by lifestyle confounding.
  • "Bulletproof coffee" / butter coffee. Calorie-dense, no demonstrated benefit over plain coffee; the saturated-fat content is meaningful.
  • Alkaline water, "structured" water, marine-plasma water. No clinical evidence of benefit beyond plain mineralised water; "structured" water is physicochemical pseudoscience. Hydrogen water has plausible biology but is still preliminary.
  • Daily electrolyte powders for sedentary adults. Not needed below about 75 minutes of sustained exertion or heat exposure; many add substantial sugar and unnecessary sodium.
  • The "J-curve" for moderate drinking. The data that supported it could not survive Mendelian-randomisation and sick-quitter adjustments.
  • Avoiding coffee for atrial fibrillation. The DECAF trial directly contradicts the historical instruction in cardioversion patients — coffee reduced recurrence by 39%.
  • Tanning-bed-like "vitamin water" infused beverages. Vitamin doses are typically negligible; sugar and sweetener loads usually are not.
— § —